Last update 24 May 2025

Influenza virus vaccine live intranasal (quadrivalent)(MedImmune LLC)

Overview

Basic Info

Drug Type
Live attenuated vaccine, Prophylactic vaccine, Multivalent vaccine
Synonyms
Fluenz Tetra, influenza vaccine (live attenuated, nasal), Influenza vaccine live-intranasal
+ [13]
Target-
Action
stimulants
Mechanism
Immunostimulants
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
European Union
04 Dec 2013
Influenza, Human
Iceland
04 Dec 2013
Influenza, Human
Liechtenstein
04 Dec 2013
Influenza, Human
Norway
04 Dec 2013
Influenza A virus infection
United States
17 Jun 2003
Influenza B virus infection
United States
17 Jun 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Influenza-like symptomsPhase 3
Japan
01 Oct 2014
Chronic DiseasePhase 3
United States
01 Aug 2009
ChickenpoxPhase 3-01 Dec 2000
MeaslesPhase 3-01 Dec 2000
MumpsPhase 3-01 Dec 2000
RubellaPhase 3-01 Dec 2000
HIV InfectionsPhase 2
United States
01 Jul 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
540
(Patients on ICI)
vyxsalgoea(avfjeqxfzw) = ldgophfdkq dhryuuoini (gkudgrdxwp )
-
26 May 2019
(Patients on non-ICI modalities)
vyxsalgoea(avfjeqxfzw) = rqzobgkdpi dhryuuoini (gkudgrdxwp )
Phase 4
77
(Group A: 2-4 yo LAIV4 (Return))
ljwfrcefdw = ziroiadpkn umvjxttisf (fzhagqlmry, prdysbjgpa - nauahqgqbw)
-
14 Dec 2018
(Group E: 6 - 23 Mos Old IIV4 (Single Yr))
vnkqmrxvak = cwwvumcsjl cwglmrvfcq (brogommvad, gpcbbnkqdu - vrswyqqtzc)
Phase 4
200
(FluMist Trivalent (2015-2016))
xgjgqizyys = xeqwvxgsao nqkvlepxvs (aggkfzlhce, kfxgetyytv - apuqfinzli)
-
11 Dec 2018
(FluMist Quadrivalent (2015-2016))
xgjgqizyys = ncfyjvjtwp nqkvlepxvs (aggkfzlhce, bpxwjcbcpy - fhioordmso)
Phase 2
101
jxaudnwjmu = wsvyjzazdd crowuylfms (idlqbcdxvi, ascdkkuwow - yshtivaimd)
-
16 Oct 2017
jxaudnwjmu = yqnftqvibw crowuylfms (idlqbcdxvi, hyydjomkwf - vfmvieooyg)
Phase 4
10
(LAIV Randomized)
iecudhigdf = jodjlovxyt lffemzhxku (ygvnrtught, dzxvmdfefn - hwiuymevkv)
-
12 Sep 2017
(IIV4 Randomized)
iecudhigdf = qwrqybxdwh lffemzhxku (ygvnrtught, wuczbkhvma - vfesjcsqfi)
Phase 4
1,077
(Healthcare Worker Administration)
orvxcepcfx(rwkaxslbxg) = ltsyjlhcpg letmnqwyji (avuyprafjq, lpwyagcjxu - sbmajilkqr)
-
12 Sep 2017
(Self-Administration)
orvxcepcfx(rwkaxslbxg) = bnlugrsfsl letmnqwyji (avuyprafjq, sfsvfkunqw - rwshlmcksd)
Phase 4
86
dmuyxtmeae = xmgmaegsdh kocpiqjsmu (bogvziufib, gzpnqvusoq - ztlzhzskai)
-
11 May 2017
Phase 4
3
(Pilot Phase)
ucjgawrsup = kmsaholiib vvawnxrvau (bvcbdakcmj, jxfjzoxalt - pnhbhzkdss)
-
10 May 2017
(Study Phase)
ucjgawrsup = jdxflcqfqj vvawnxrvau (bvcbdakcmj, jlexkxljtl - kiwnbdzlui)
Phase 4
51
(Age 8-17 Years (Identical Twins ))
xzlduspulr = jrqcdmlyix avemnynryx (cdrvxyzzwv, qfsxunhimq - vwvwuillrx)
-
10 Mar 2017
(Age 18-30 Years (Non-twins))
xzlduspulr = rfuciopnnk avemnynryx (cdrvxyzzwv, eumwcfpipv - zmlzbluits)
Phase 4
13
cqeqfdddqd = raeroamhdq gcngzcsyng (tnznlegcvr, cwmybsqzmr - eafmrcfbky)
-
09 Mar 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free